Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 10/5/20021 min de lectura
Pediculicide Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is proposing to amend the final monograph for over-the-counter (OTC) pediculicide drug products to revise labeling for the statement of identity, warnings, directions, and other required statements. Pediculicide drug products are used for the treatment of head, pubic (crab), and body lice. This proposal is part of FDA's ongoing review of OTC drug products.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →